Blood in the urine, medically called hematuria, is blood that reaches your urine anywhere along the urinary tract, from the kidney's filtering units to the urethra. Visible blood makes urine pink, red, or cola-colored; microscopic hematuria means blood appears only on testing, at three or more red blood cells per high-power microscope field on a urine sample. Roughly half of people with microscopic hematuria have no identifiable cause even after full evaluation, yet about 1 to 3 percent of them carry a urinary tract cancer. Visible blood in the urine is different: it demands evaluation in essentially every adult, because 8 to 30 percent of visible-blood cases turn out to be cancer.
What blood in the urine is actually telling you
Your kidneys filter about 180 liters of plasma daily, then reabsorb almost all of it. Roughly 1 liter leaves as urine. Red blood cells are too large to pass the glomerular filter under normal pressure, so any red cell that survives into the bladder means something upstream has broken.
Three mechanisms produce hematuria. Glomerular bleeding happens when the filtration membrane itself is damaged, as in IgA nephropathy or glomerulonephritis. Non-glomerular bleeding comes from structural lesions: stones scraping the ureter, tumors eroding blood vessels, or infection inflaming the bladder lining. Third, systemic problems like clotting disorders or sickle cell disease leak blood without any urinary tract lesion at all.
The glomerular filter adds a diagnostic clue. When red cells squeeze through a damaged glomerulus, they deform. A lab sees this as dysmorphic red cells plus protein in the urine, which points upstream to the kidney rather than down to the bladder. In plain terms: the shape of the red cell tells you whether the leak is in the kidney's filter or somewhere below it.
How common hematuria is, and what it predicts
Microscopic hematuria appears in roughly 2 to 13 percent of adults, depending on the population screened and the definition used. The prevalence is higher in older adults and in people with diabetes or hypertension. Men over 60 with microscopic hematuria carry an elevated cancer risk compared with the general screened population.
The predictive numbers matter most. Per the 2012 American Urological Association guideline, visible hematuria carries an 8 to 30 percent cancer risk, while microscopic hematuria carries 1 to 3 percent. Age is the sharpest modifier: cancer risk in microscopic hematuria climbs steadily after age 40 and rises faster after 60.
The 2020 AUA/SUFU guideline sets a stricter testing threshold than older definitions. It defines microscopic hematuria as three or more red blood cells per high-power field on two of three properly collected specimens. This matters because transient hematuria is common. A single flagged dipstick should not trigger imaging, but persistent findings should.
Visible versus microscopic: same word, different urgency
The two halves of hematuria diverge sharply in urgency, workup, and cancer risk. One is a symptom that usually needs imaging within weeks. The other is a screening finding that needs confirmation before it needs a scanner.
| Feature | Visible (gross) hematuria | Microscopic hematuria |
|---|---|---|
| Typical detection | Patient notices pink, red, or cola urine | Found on dipstick or urinalysis |
| Cancer risk | 8 to 30 percent | 1 to 3 percent |
| First step | Urinalysis and urine culture, then imaging | Confirm persistence on repeat testing |
| Imaging in adults | CT urography or ultrasound, generally within weeks | CT urography or renal ultrasound if risk factors present |
| Cystoscopy | Recommended in most adults over 40 | Recommended if risk factors, or age over 60 |
| Blood thinners | Do not explain bleeding away; still evaluate | Same |
| Pain level | Painful bleeding is more often infection or stone | Usually painless and incidental |
One table entry deserves emphasis: anticoagulants. A patient on warfarin or a direct oral anticoagulant who has blood in the urine is often assumed to have a drug-related bleed. Professional guidance rejects that shortcut. Anticoagulation may unmask a tumor rather than cause the bleeding, so the evaluation proceeds the same way. This is among the most important corrected misconceptions in the field.
Timeline: how long blood in the urine should take to work up
Time course varies by presentation. The table below reflects standard urologic practice, not a single mandatory protocol; individual clinicians individualize.
| Stage | Typical timing | What happens |
|---|---|---|
| Transient episode | 0 to 72 hours | Repeat urinalysis after infection is treated or after vigorous exercise stops |
| Confirmation of microscopic hematuria | 2 to 6 weeks | Two of three specimens show 3+ red cells per high-power field |
| Initial evaluation | Within 4 to 8 weeks of confirmation | History, medication review, blood pressure, creatinine, urine culture |
| Imaging (CT urography) | Within 2 to 4 weeks of visible blood | Assesses kidneys, ureters, and bladder for stones, tumors, and structural lesions |
| Cystoscopy | Within 2 to 4 weeks in adults over 40 with visible blood | Direct inspection of the bladder lining |
| Referral for persistent or unexplained findings | Within 4 to 12 weeks | Urology or nephrology depending on protein, dysmorphic cells, or creatinine |
| Repeat testing if workup is negative | 6 to 12 months | Recheck to catch a lesion missed or developing later |
The first row carries a caveat. Up to one-third of single positive dipsticks do not repeat on a proper repeat test, so rushing to a CT scan after one reading wastes money and delivers radiation unnecessarily. The confirmation step is not delay; it is triage.
When the answer is not in the bladder: non-obvious causes
Kidney stones cause pain that radiates from flank to groin, and the bleeding typically follows the pain. Cystitis causes burning with urination. Both are common and self-limiting with treatment. The catch is that pain does not rule out cancer, and painless bleeding does not rule out infection.
Beyond the obvious, several edge cases deserve attention. Exercise-induced hematuria appears after intense exertion, especially running, affecting a meaningful share of endurance athletes; it clears with rest. Sickle cell trait affects roughly 1 in 13 Black Americans and can cause painless hematuria from renal papillary necrosis, a microinfarct of the kidney's inner tissue. IgA nephropathy often presents after an upper respiratory infection, with cola-colored urine and protein in the sample.
Glomerular disease adds a key discriminator. When urine shows protein plus red cell casts, the workup shifts toward nephrology and away from urology. A red cell cast is a microscopic mold of a kidney tubule; finding one is close to proof the bleeding source is in the kidney filter, not the bladder.
Ruling out the dangerous causes: red flags
Most hematuria is benign, but certain features raise the probability of malignancy or serious disease enough that they change urgency. The items below warrant prompt evaluation, generally within days rather than weeks.
- Visible blood in the urine in anyone over 40, even when painless
- Blood clots in the urine, or bleeding heavy enough to obstruct urine flow
- Flank pain with fever, which may signal a blocked infected kidney
- Unexplained weight loss, night sweats, or a palpable mass
- Hematuria with known risk factors: smoking history, occupational chemical exposure, or pelvic radiation
- Persistent microscopic hematuria with protein in the sample or rising creatinine
Smoking deserves separate mention. It is among the strongest modifiable risk factors for bladder cancer, and a smoking history of 20 pack-years or more raises the pre-test probability of a tumor substantially in a person with visible bleeding.
What to actually do when you see blood in the urine
First, do not panic, and do not self-treat. Visible blood in the urine in an adult is a medical visit, not a wait-and-see. Make the appointment within days.
Second, keep a simple record. Note the date, the color, whether urination was painful, whether you had a fever, and any recent exercise or new medicines. This history shapes the first visit more than any single test.
Third, hydrate normally and avoid NSAIDs like ibuprofen until evaluated. These drugs can worsen kidney function in a person who already has a kidney problem, and they can also cause a false dipstick reading.
Fourth, expect urinalysis and a urine culture first. Do not accept a CT scan the same day unless the bleeding is heavy and persistent. The confirmation step follows the 2020 AUA threshold of three red cells per high-power field on two of three samples.
Fifth, follow through on cystoscopy if recommended. Cystoscopy, a camera inspection of the bladder, detects small bladder tumors that CT can miss, especially in adults over 40 with visible blood.
Sixth, return for rechecking. If imaging and cystoscopy are clean and the bleeding stops, a follow-up urinalysis at 6 to 12 months is still reasonable, because a small percentage of negative workups later reveal a lesion.
Limits of testing, and where certainty ends
No single test rules out urinary tract cancer. CT urography misses some small flat bladder lesions; cystoscopy misses some ureteral tumors. Sensitivity is high but not perfect, and false reassurance after one round of tests is a documented failure mode.
The numbers carry uncertainty too. The cancer-risk ranges cited above, 8 to 30 percent for visible blood and 1 to 3 percent for microscopic, describe screened populations, not individuals. A 30-year-old with microscopic hematuria has a different risk than a 70-year-old smoker with the same finding. These probabilities are sharpened by age, smoking history, and symptom pattern, and any figure cited by a clinician should be read as a range rather than a verdict.
Then there is the unresolved question: what does unexplained hematuria mean biologically? Roughly half of microscopic cases remain without a cause after full evaluation. In most, the bleeding is benign and self-limited. In a minority, it precedes detection of a lesion by months. The current standard is repeat testing rather than invasive hunting for a source that may never declare itself.
The one constant across both visible and microscopic hematuria: the first step is a conversation, not a scan. A single episode of blood in the urine is a signal worth respecting, and a well-organized workup converts an alarming sight into a manageable plan.